ATE137116T1 - Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen - Google Patents

Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen

Info

Publication number
ATE137116T1
ATE137116T1 AT91306069T AT91306069T ATE137116T1 AT E137116 T1 ATE137116 T1 AT E137116T1 AT 91306069 T AT91306069 T AT 91306069T AT 91306069 T AT91306069 T AT 91306069T AT E137116 T1 ATE137116 T1 AT E137116T1
Authority
AT
Austria
Prior art keywords
treatment
inflammatory diseases
ketoprostaglandins
medicament
manufacture
Prior art date
Application number
AT91306069T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE137116T1 publication Critical patent/ATE137116T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91306069T 1990-07-10 1991-07-03 Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen ATE137116T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18496390 1990-07-10

Publications (1)

Publication Number Publication Date
ATE137116T1 true ATE137116T1 (de) 1996-05-15

Family

ID=16162415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91306069T ATE137116T1 (de) 1990-07-10 1991-07-03 Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen

Country Status (10)

Country Link
US (1) US5346921A (de)
EP (1) EP0467564B1 (de)
JP (1) JP2562239B2 (de)
KR (1) KR100195430B1 (de)
AT (1) ATE137116T1 (de)
CA (1) CA2046069C (de)
DE (1) DE69118978T2 (de)
DK (1) DK0467564T3 (de)
ES (1) ES2089136T3 (de)
GR (1) GR3019760T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508302A (en) * 1994-09-28 1996-04-16 American Home Products Corporation Phospholipase A2 inhibitors
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
DE69714698T2 (de) * 1996-06-10 2002-12-05 Sucampo Ag, Zug Endothelin-antagonisten
NZ336960A (en) * 1997-11-28 2001-02-23 R Tech Ueno Ltd Use of 15-keto-prostaglandin E compounds for the preparation of medicaments for use as endothelin antagonists
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
PT1220849E (pt) 1999-10-15 2004-10-29 Sucampo Ag Composicao de compostos biciclicos e metodo para a sua estabilizacao
AR035242A1 (es) * 2001-05-18 2004-05-05 Sucampo Ag Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado
CA2458230A1 (en) * 2001-08-23 2003-03-06 Sucampo Ag Method and composition for treatment of ocular hypertension and glaucoma
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
ATE489955T1 (de) * 2005-03-04 2010-12-15 Sucampo Ag Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US20140212441A1 (en) * 2011-06-21 2014-07-31 R-Tech Ueno, Ltd. Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
KR102578588B1 (ko) * 2021-07-22 2023-09-14 정찬희 자석이 구비된 도어 잠금장치

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2321876A1 (fr) * 1975-08-29 1977-03-25 Roussel Uclaf Nouveaux derives cyclopentaniques, leur procede de preparation et leur application comme medicaments
US4097603A (en) * 1977-09-06 1978-06-27 The Upjohn Company Gastric cytoprotection with non-antisecretory doses of prostaglandins
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
JPS59134746A (ja) * 1982-11-05 1984-08-02 ザ，プロクタ−，エンド，ギヤンブル，カンパニ− 新規プロスタグランジン類似体
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
US4612330A (en) * 1985-02-04 1986-09-16 Eli Lilly And Company Antiinflammatory method
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.
JP2515442B2 (ja) * 1990-05-01 1996-07-10 株式会社上野製薬応用研究所 膵臓疾患処置剤

Also Published As

Publication number Publication date
JPH0532551A (ja) 1993-02-09
ES2089136T3 (es) 1996-10-01
DE69118978T2 (de) 1996-11-14
US5346921A (en) 1994-09-13
KR100195430B1 (ko) 1999-06-15
CA2046069C (en) 2002-04-09
CA2046069A1 (en) 1992-01-11
EP0467564B1 (de) 1996-04-24
GR3019760T3 (en) 1996-07-31
KR920002151A (ko) 1992-02-28
EP0467564A2 (de) 1992-01-22
DK0467564T3 (da) 1996-05-13
DE69118978D1 (de) 1996-05-30
EP0467564A3 (en) 1992-07-08
JP2562239B2 (ja) 1996-12-11

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69304955D1 (de) Behandlung von neurodegenerativen Erkrankungen
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time